Open Site Navigation

Networking Purists

We have seen this industry grow, adapt, evolve. Yet, today, we still keep our networking in its purest form for the leaders we serve. Personal contact. Whether sitting with a client or speaking over the phone, we believe physical contact is the most powerful way of communication. 

Less Is More, Not Quantity

Exceptional care ensures that each attendee is invited for their relevance, influence and seniority in the industry. 

This means our delegation will be end-users only. There are no headhunters, press, or interns; instead, it’s a meeting led by decision-makers or end-users who possess incredible influence and authority.

Focus on Challenges Not Pitches

All presentations undergo a rigorous revision process to ensure they are engaging, informative and with data that can be transformed into actionable results.

Speakers 30%

End Users 60%

Buying Power 90%

Vendors 10%

Our Events

14th Annual Drug Discovery to Development Innovation Forum 2022 

5th Annual Cell And Gene Therapy Innovation Summit 2022

9th Annual Supply Chain Innovation Leaders Summit 2022

14th Annual Bio Innovation Leaders Summit 2022

WE ARE PASSIONATE

We are passionate about bringing together some of the world's leading industry vanguards to empower, stimulate minds, and advance.

GBX Events

We Are Committed To Help Organizations Advance 

Learn more

Our Events

Learn more

Get Tickets

Learn more

Covid - 19

Our Mission

The Mission

Our mission is to continue producing cutting-edge programmes that transform, inspire, and empower decision making for some of the worlds elite business leaders from innovative industries such as AI, life sciences and manufacturing.

We Are Committed

Raison d'être

Since 2007

GBX Events

Why Partner With Us?

Advisory

Proud to bring inspirational leaders from across the globe

Ted Torphy

Dr. Ted Torphy brings to BioMotiv over 30 years of experience in the pharmaceutical industry with a successful record in both small-molecule and large-molecule drug discovery and preclinical development.

Patrick Basanez

An accomplished professional with up to 15 years of industry experience of which over ten years focused on senior management experience.

Thomas Herget

Prof. Dr. Thomas Herget is currently Head of Processing Technologies within the Merck Millipore process solutions division of Merck KGaA, where he develops new methods and materials for bioprocessing.

Dorothee Ambrosius

Dorothee joined the leadership team of Boehringer Ingelheim on October 1, 2010 as Senior Vice President, Global Process Science. Her knowledge and over 20 years experience in research and development of Biopharmaceuticals

Uwe Gottschalk

Uwe Gottschalk is Chief Scientific Officer (CSO) at Lonza since July 2017. Between 2014 and 2017 he served as a Chief Technology Officer where he established and led the global Research and Technology organisation of Lonza Pharma/Biotech.

Dave Malenfant

Dave Malenfant is Director, Outreach & Partnerships, Center for Supply Chain Innovation, at the Texas Christian University Neeley School of Business in Fort Worth, TX. He has more than 25 years of experience in driving change and performance

Partners

Our Journey

Subscribe to Our Mailing List

Thanks for submitting!

G

B

X